LAS VEGAS, Dec. 9, 2019 — GVB Biopharma, a leading hemp cannabinoid producer, announced today that its research and development team has identified and isolated a previously unstudied cannabinoid called cannabicitran, or CBT. This group of scientists, comprised of alumni from the world’s leading pharmaceutical companies, will be able to study the structure, function and potential benefits … Continue reading GVB Biopharma Begins Research on CBT (Cannabicitran), Unexplored Cannabinoid